Download PDF

Other users also viewed these articles

Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review Luis Gutiérrez-Rojas; Jesús José de la Gándara Martín; Luisa García Buey; Juan I. Uriz Otano; Álvaro Mena; Carlos Roncero;
Gastroenterol Hepatol. 2023;46:382-96
Externalized nurse-led model for hepatitis C virus microelimination and impact of drug use profile Anna Miralpeix; Paula Ibáñez; Víctor Navarro; Patricia Colomera; Montserrat Gálvez; Zoe Mariño; Xavier Major; Joan Colom; Xavier Forns; Sabela Lens;
Gastroenterol Hepatol. 2025;48:
Coordinated assistance plan for the elimination of hepatitis C virus at the centro de ayuda integral al drogodependiente (CAID (Comprehensive Care Centre for Drug Addicts)) María Luisa Gutiérrez García; Raquel Gómez Perosanz; Juan Manuel Acedo Sanz; Alberto Delgado-Iribarren García-Campero; Itziar Claudio Domínguez; Angela Domenech Gómez-Imaz; Montserrat Pérez Encinas; Inés de la Fuente Hermosín; Aurora Fabero Jimenez; Conrado M. Fernández Rodríguez;
Gastroenterol Hepatol. 2021;44:214-20